BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sadek B, Stark H. Cherry-picked ligands at histamine receptor subtypes. Neuropharmacology 2016;106:56-73. [PMID: 26581501 DOI: 10.1016/j.neuropharm.2015.11.005] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Mehta P, Miszta P, Filipek S. Molecular Modeling of Histamine Receptors-Recent Advances in Drug Discovery. Molecules 2021;26:1778. [PMID: 33810008 DOI: 10.3390/molecules26061778] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Ghamari N, Zarei O, Arias-Montaño JA, Reiner D, Dastmalchi S, Stark H, Hamzeh-Mivehroud M. Histamine H3 receptor antagonists/inverse agonists: Where do they go? Pharmacol Ther 2019;200:69-84. [PMID: 31028835 DOI: 10.1016/j.pharmthera.2019.04.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
3 Sadek B, Khan N, Darras FH, Pockes S, Decker M. The dual-acting AChE inhibitor and H3 receptor antagonist UW-MD-72 reverses amnesia induced by scopolamine or dizocilpine in passive avoidance paradigm in rats. Physiology & Behavior 2016;165:383-91. [DOI: 10.1016/j.physbeh.2016.08.022] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
4 Eissa N, Jayaprakash P, Azimullah S, Ojha SK, Al-Houqani M, Jalal FY, Łażewska D, Kieć-Kononowicz K, Sadek B. The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism. Sci Rep 2018;8:13077. [PMID: 30166610 DOI: 10.1038/s41598-018-31385-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
5 Alhusaini M, Eissa N, Saad AK, Beiram R, Sadek B. Revisiting Preclinical Observations of Several Histamine H3 Receptor Antagonists/Inverse Agonists in Cognitive Impairment, Anxiety, Depression, and Sleep-Wake Cycle Disorder. Front Pharmacol 2022;13:861094. [PMID: 35721194 DOI: 10.3389/fphar.2022.861094] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Schnedl WJ, Lackner S, Enko D, Schenk M, Holasek SJ, Mangge H. Evaluation of symptoms and symptom combinations in histamine intolerance. Intest Res 2019;17:427-33. [PMID: 30836736 DOI: 10.5217/ir.2018.00152] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
7 Chu CC, Zhao SZ. Pathophysiological Role and Drug Modulation of Calcium Transport in Ocular Surface Cells. Curr Med Chem 2020;27:5078-91. [PMID: 31237195 DOI: 10.2174/0929867326666190619114848] [Reference Citation Analysis]
8 Gangwar RS, Landolina N, Arpinati L, Levi-Schaffer F. Mast cell and eosinophil surface receptors as targets for anti-allergic therapy. Pharmacol Ther. 2017;170:37-63. [PMID: 27773785 DOI: 10.1016/j.pharmthera.2016.10.010] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
9 Sadek B, Saad A, Sadeq A, Jalal F, Stark H. Histamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseases. Behav Brain Res 2016;312:415-30. [PMID: 27363923 DOI: 10.1016/j.bbr.2016.06.051] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 11.3] [Reference Citation Analysis]
10 Alachkar A, Khan N, Łażewska D, Kieć-Kononowicz K, Sadek B. Histamine H3 receptor antagonist E177 attenuates amnesia induced by dizocilpine without modulation of anxiety-like behaviors in rats. Neuropsychiatr Dis Treat 2019;15:531-42. [PMID: 30863075 DOI: 10.2147/NDT.S193125] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
11 Kotańska M, Mika K, Reguła K, Szczepańska K, Szafarz M, Bednarski M, Olejarz-maciej A, Nowak K, Latacz G, Mogilski S, Kuder KJ, Kieć-kononowicz K, Sapa J. KSK19 – Novel histamine H3 receptor ligand reduces body weight in diet induced obese mice. Biochemical Pharmacology 2019;168:193-203. [DOI: 10.1016/j.bcp.2019.07.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
12 Schnedl WJ, Mangge H, Schenk M, Enko D. Non-responsive celiac disease may coincide with additional food intolerance/malabsorption, including histamine intolerance. Med Hypotheses 2021;146:110404. [PMID: 33268003 DOI: 10.1016/j.mehy.2020.110404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Schnedl WJ, Enko D. Considering histamine in functional gastrointestinal disorders. Crit Rev Food Sci Nutr 2020;:1-8. [PMID: 32643952 DOI: 10.1080/10408398.2020.1791049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
14 Monczor F, Fernandez N. Current Knowledge and Perspectives on Histamine H1 and H2 Receptor Pharmacology: Functional Selectivity, Receptor Crosstalk, and Repositioning of Classic Histaminergic Ligands. Mol Pharmacol 2016;90:640-8. [PMID: 27625037 DOI: 10.1124/mol.116.105981] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
15 Velez TE, Bryce PJ, Hulse KE. Mast Cell Interactions and Crosstalk in Regulating Allergic Inflammation. Curr Allergy Asthma Rep 2018;18:30. [PMID: 29667026 DOI: 10.1007/s11882-018-0786-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
16 Pisera-fuster A, Otero S, Talevi A, Bruno-blanch L, Bernabeu R. Anticonvulsant effect of sodium cyclamate and propylparaben on pentylenetetrazol-induced seizures in zebrafish: PISERA-FUSTER et al. Synapse 2017;71:e21961. [DOI: 10.1002/syn.21961] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
17 Ranjbar M, Ghafouri H, Salehi F, Emami L, Khonya N, Rezaei Z, Sakhteman A. Homology Modeling, Molecular Dynamics Simulation and Cross-Docking Studies of Human Histamine-2 (H2) Receptor to Obtain a 3D Structure for Further SBDD Studies. J of Biological Sciences 2019;20:22-31. [DOI: 10.3923/jbs.2020.22.31] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Alachkar A, Lotfy M, Adeghate E, Łażewska D, Kieć-Kononowicz K, Sadek B. Ameliorating effects of histamine H3 receptor antagonist E177 on acute pentylenetetrazole-induced memory impairments in rats. Behav Brain Res 2021;405:113193. [PMID: 33626390 DOI: 10.1016/j.bbr.2021.113193] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Schnedl WJ, Lackner S, Enko D, Schenk M, Mangge H, Holasek SJ. Non-celiac gluten sensitivity: people without celiac disease avoiding gluten-is it due to histamine intolerance? Inflamm Res 2018;67:279-84. [PMID: 29181545 DOI: 10.1007/s00011-017-1117-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
20 Haas HL, Panula P. Histamine receptors. Neuropharmacology 2016;106:1-2. [DOI: 10.1016/j.neuropharm.2016.04.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
21 Sadek B, Saad A, Latacz G, Kuder K, Olejarz A, Karcz T, Stark H, Kieć-Kononowicz K. Non-imidazole-based histamine H3 receptor antagonists with anticonvulsant activity in different seizure models in male adult rats. Drug Des Devel Ther 2016;10:3879-98. [PMID: 27932863 DOI: 10.2147/DDDT.S116192] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 3.2] [Reference Citation Analysis]
22 Adami M, Micheloni C, Grandi D, Stark H. Differential effects of functionally different histamine H4 receptor ligands on acute irritant dermatitis in mice. Naunyn Schmiedebergs Arch Pharmacol 2018;391:1387-97. [PMID: 30145688 DOI: 10.1007/s00210-018-1553-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Eissa N, Azimullah S, Jayaprakash P, Jayaraj RL, Reiner D, Ojha SK, Beiram R, Stark H, Łażewska D, Kieć-kononowicz K, Sadek B. The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium valproate induced autism in mice. Chemico-Biological Interactions 2019;312:108775. [DOI: 10.1016/j.cbi.2019.108775] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
24 Rapanelli M. The magnificent two: histamine and the H3 receptor as key modulators of striatal circuitry. Prog Neuropsychopharmacol Biol Psychiatry 2017;73:36-40. [PMID: 27773554 DOI: 10.1016/j.pnpbp.2016.10.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
25 Eissa N, Sadeq A, Sasse A, Sadek B. Role of Neuroinflammation in Autism Spectrum Disorder and the Emergence of Brain Histaminergic System. Lessons Also for BPSD? Front Pharmacol 2020;11:886. [PMID: 32612529 DOI: 10.3389/fphar.2020.00886] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
26 He M, Lippestad M, Li D, Hodges RR, Utheim TP, Dartt DA. Activation of the EGF Receptor by Histamine Receptor Subtypes Stimulates Mucin Secretion in Conjunctival Goblet Cells. Invest Ophthalmol Vis Sci 2018;59:3543-53. [PMID: 30025103 DOI: 10.1167/iovs.18-2476] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
27 Schlicker E, Kathmann M. Role of the Histamine H3 Receptor in the Central Nervous System. Handb Exp Pharmacol 2017;241:277-99. [PMID: 27787717 DOI: 10.1007/164_2016_12] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
28 Fernandes C, Serafim K, Gianlorenço A, Mattioli R. Cholinergic agonist reverses H1-induced memory deficit in mice. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2017;72:16-22. [DOI: 10.1016/j.pnpbp.2016.08.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
29 Venkatachalam K, Eissa N, Awad MA, Jayaprakash P, Zhong S, Stölting F, Stark H, Sadek B. The histamine H3R and dopamine D2R/D3R antagonist ST-713 ameliorates autism-like behavioral features in BTBR T+tf/J mice by multiple actions. Biomed Pharmacother 2021;138:111517. [PMID: 33773463 DOI: 10.1016/j.biopha.2021.111517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Madariaga-Mazón A, Marmolejo-Valencia AF, Li Y, Toll L, Houghten RA, Martinez-Mayorga K. Mu-Opioid receptor biased ligands: A safer and painless discovery of analgesics? Drug Discov Today 2017;22:1719-29. [PMID: 28743488 DOI: 10.1016/j.drudis.2017.07.002] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 13.0] [Reference Citation Analysis]
31 Alachkar A, Łażewska D, Kieć-Kononowicz K, Sadek B. The Histamine H3 Receptor Antagonist E159 Reverses Memory Deficits Induced by Dizocilpine in Passive Avoidance and Novel Object Recognition Paradigm in Rats. Front Pharmacol 2017;8:709. [PMID: 29075190 DOI: 10.3389/fphar.2017.00709] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
32 Szczepańska K, Karcz T, Kotańska M, Siwek A, Kuder KJ, Latacz G, Mogilski S, Hagenow S, Lubelska A, Sobolewski M, Stark H, Kieć-Kononowicz K. Optimization and preclinical evaluation of novel histamine H3receptor ligands: Acetyl and propionyl phenoxyalkyl piperazine derivatives. Bioorg Med Chem 2018;26:6056-66. [PMID: 30448256 DOI: 10.1016/j.bmc.2018.11.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
33 Szczepańska K, Karcz T, Mogilski S, Siwek A, Kuder KJ, Latacz G, Kubacka M, Hagenow S, Lubelska A, Olejarz A, Kotańska M, Sadek B, Stark H, Kieć-Kononowicz K. Synthesis and biological activity of novel tert-butyl and tert-pentylphenoxyalkyl piperazine derivatives as histamine H3R ligands. Eur J Med Chem 2018;152:223-34. [PMID: 29723785 DOI: 10.1016/j.ejmech.2018.04.043] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
34 Akimoto H, Sugihara M, Hishinuma S. Differential Regulation of Bilastine Affinity for Human Histamine H1 Receptors by Lys 179 and Lys 191 via Its Binding Enthalpy and Entropy. Int J Mol Sci 2021;22:1655. [PMID: 33562121 DOI: 10.3390/ijms22041655] [Reference Citation Analysis]
35 Taheri F, Esmaeilpour K, Sepehri G, Sheibani V, Ur Rehman N, Maneshian M. Histamine H3 receptor antagonist, ciproxifan, alleviates cognition and synaptic plasticity alterations in a valproic acid-induced animal model of autism. Psychopharmacology (Berl) 2022. [PMID: 35538250 DOI: 10.1007/s00213-022-06155-z] [Reference Citation Analysis]
36 Tanaka S, Sakaguchi M, Yoneyama H, Usami Y, Harusawa S. Histamine H3 receptor antagonist OUP-186 attenuates the proliferation of cultured human breast cancer cell lines. Biochemical and Biophysical Research Communications 2016;480:479-85. [DOI: 10.1016/j.bbrc.2016.10.077] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
37 Oliveira CC, Oliveira CV, Grigoletto J, Ribeiro LR, Funck VR, Meier L, Fighera MR, Royes LFF, Furian AF, Menezes IRA, Oliveira MS. Anticonvulsant activity of Caryocar coriaceum Wittm. fixed pulp oil against pentylenetetrazol-induced seizures. Neurological Research 2017;39:667-74. [DOI: 10.1080/01616412.2017.1324380] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
38 Bastaki SM, Abdulrazzaq YM, Shafiullah M, Więcek M, Kieć-Kononowicz K, Sadek B. Anticonvulsant and reproductive toxicological studies of the imidazole-based histamine H3R antagonist 2-18 in mice. Drug Des Devel Ther 2018;12:179-94. [PMID: 29403264 DOI: 10.2147/DDDT.S144730] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
39 Eissa N, Azimullah S, Jayaprakash P, Jayaraj RL, Reiner D, Ojha SK, Beiram R, Stark H, Łażewska D, Kieć-Kononowicz K, Sadek B. The Dual-Active Histamine H3 Receptor Antagonist and Acetylcholine Esterase Inhibitor E100 Alleviates Autistic-Like Behaviors and Oxidative Stress in Valproic Acid Induced Autism in Mice. Int J Mol Sci 2020;21:E3996. [PMID: 32503208 DOI: 10.3390/ijms21113996] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
40 Shen C, Chen F, Wang H, Zhang X, Li G, Wen Z. Individualized treatment for allergic rhinitis based on key nasal clinical manifestations combined with histamine and leukotriene D4 levels. Braz J Otorhinolaryngol 2020;86:63-73. [PMID: 30467056 DOI: 10.1016/j.bjorl.2018.09.007] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
41 Shteinikov VY, Korosteleva AS, Tikhonova TB, Potapieva NN, Tikhonov DB. Ligands of histamine receptors modulate acid-sensing ion channels. Biochem Biophys Res Commun 2017;490:1314-8. [PMID: 28688766 DOI: 10.1016/j.bbrc.2017.07.019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
42 Guilherme EM, Silva-Marques B, Fernandes CEM, Russo TL, Mattioli R, Gianlorenço AC. Intracerebellar microinjection of histaminergic compounds on locomotor and exploratory behaviors in mice. Neurosci Lett 2018;687:10-5. [PMID: 30218765 DOI: 10.1016/j.neulet.2018.09.022] [Reference Citation Analysis]
43 Sloop KW, Emmerson PJ, Statnick MA, Willard FS. The current state of GPCR-based drug discovery to treat metabolic disease. Br J Pharmacol 2018;175:4060-71. [PMID: 29394497 DOI: 10.1111/bph.14157] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
44 Eissa N, Jayaprakash P, Stark H, Łażewska D, Kieć-Kononowicz K, Sadek B. Simultaneous Blockade of Histamine H3 Receptors and Inhibition of Acetylcholine Esterase Alleviate Autistic-Like Behaviors in BTBR T+ tf/J Mouse Model of Autism. Biomolecules 2020;10:E1251. [PMID: 32872194 DOI: 10.3390/biom10091251] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
45 Eissa N, Venkatachalam K, Jayaprakash P, Falkenstein M, Dubiel M, Frank A, Reiner-Link D, Stark H, Sadek B. The Multi-Targeting Ligand ST-2223 with Histamine H3 Receptor and Dopamine D2/D3 Receptor Antagonist Properties Mitigates Autism-Like Repetitive Behaviors and Brain Oxidative Stress in Mice. Int J Mol Sci 2021;22:1947. [PMID: 33669336 DOI: 10.3390/ijms22041947] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Eissa N, Al-Houqani M, Sadeq A, Ojha SK, Sasse A, Sadek B. Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder. Front Neurosci 2018;12:304. [PMID: 29867317 DOI: 10.3389/fnins.2018.00304] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 14.8] [Reference Citation Analysis]
47 Eissa N, Khan N, Ojha SK, Łazewska D, Kieć-Kononowicz K, Sadek B. The Histamine H3 Receptor Antagonist DL77 Ameliorates MK801-Induced Memory Deficits in Rats. Front Neurosci 2018;12:42. [PMID: 29483860 DOI: 10.3389/fnins.2018.00042] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
48 Alachkar A, Łażewska D, Latacz G, Frank A, Siwek A, Lubelska A, Honkisz-Orzechowska E, Handzlik J, Stark H, Kieć-Kononowicz K, Sadek B. Studies on Anticonvulsant Effects of Novel Histamine H3R Antagonists in Electrically and Chemically Induced Seizures in Rats. Int J Mol Sci 2018;19:E3386. [PMID: 30380674 DOI: 10.3390/ijms19113386] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
49 Sadek B, Saad A, Schwed JS, Weizel L, Walter M, Stark H. Anticonvulsant effects of isomeric nonimidazole histamine H3 receptor antagonists. Drug Des Devel Ther 2016;10:3633-51. [PMID: 27853355 DOI: 10.2147/DDDT.S114147] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
50 Tatarkiewicz J, Rzodkiewicz P, Żochowska M, Staniszewska A, Bujalska-Zadrożny M. New antihistamines - perspectives in the treatment of some allergic and inflammatory disorders. Arch Med Sci 2019;15:537-53. [PMID: 30899308 DOI: 10.5114/aoms.2017.68534] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
51 Reiner D, Zivkovic A, Labeeuw O, Krief S, Capet M, Stark H. Novel pyrrolidinone derivative lacks claimed histamine H3 receptor stimulation in receptor binding and functional studies. Eur J Med Chem 2020;191:112150. [PMID: 32105981 DOI: 10.1016/j.ejmech.2020.112150] [Reference Citation Analysis]
52 Mehta P, Miszta P, Rzodkiewicz P, Michalak O, Krzeczyński P, Filipek S. Enigmatic Histamine Receptor H4 for Potential Treatment of Multiple Inflammatory, Autoimmune, and Related Diseases. Life (Basel) 2020;10:E50. [PMID: 32344736 DOI: 10.3390/life10040050] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]